Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 315 articles: HTML format

Single Articles

December 2025
1. CHEN X, Bao Y, Wang J
   Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
   Int J Cardiol. 2025;441:133697.
   PubMed    
   
   
   
2. ZHANG R, Jiang B, Zhao W, Liu J, et al
   A combined radiomics-clinical model for early detection of coronary plaque development in coronary CT angiography-negative populations.
   Int J Cardiol. 2025;441:133778.
   PubMed     Abstract available
   
   
   
3. MASUDA Y, Takeshita R, Tsujimoto A, Sahashi Y, et al
   Automated coronary artery segmentation / tissue characterization and detection of lipid-rich plaque: An integrated backscatter intravascular ultrasound study.
   Int J Cardiol. 2025;441:133744.
   PubMed     Abstract available
   
   
   
4. BENEDETTI A, Fusi C, Coeman M, Ghafari C, et al
   Deferred revascularization of left main stenosis based on instantaneous wave-free ratio: Long-term clinical outcomes from the PHYNAL registry.
   Int J Cardiol. 2025;441:133745.
   PubMed     Abstract available
   
   
   
5. DILENA DD, Huang J, Rauchwerger AS, Reed ME, et al
   Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.
   Int J Cardiol. 2025;440:133730.
   PubMed     Abstract available
   
   
   
6. LI S, Bo K, Ma W, Li W, et al
   Impact of metabolic dysfunction-associated fatty liver disease on left ventricular function and myocardial strain in patients with ASTEMI: Insights from a 3.0-T cardiac magnetic resonance study.
   Int J Cardiol. 2025;440:133709.
   PubMed     Abstract available
   
   
   
7. LIU C, Yang F, Hu Y, Wang L, et al
   Relationship between coronary artery calcification and plaque vulnerability, a qualitative and quantitative optical coherence tomography study.
   Int J Cardiol. 2025;440:133707.
   PubMed     Abstract available
   
   
   
8. KOCH T, Tauchmann L, Cassese S, Xhepa E, et al
   Long-term safety and efficacy of rotational atherectomy for lesion preparation of calcified coronary lesions.
   Int J Cardiol. 2025;440:133711.
   PubMed     Abstract available
   
   
   
9. RALLIDIS LS, Tsamoulis D, Papathanasiou KA, Kalogeras P, et al
   Eligibility for icosapent ethyl 1-3 months after acute coronary syndrome and the risk for myocardial re-infarction: Data from the CALLINICUS-Hellas Registry.
   Int J Cardiol. 2025;440:133684.
   PubMed     Abstract available
   
   
   November 2025
10. GIACOBBE F, Bruno F, Giannino G, Angelini F, et al
    Safety and efficacy of P2Y12 inhibitors in acute coronary syndromes patients with KDIGO stage IV-V renal disfunction not on dialysis: a subanalysis of the CORALYS registry.
    Int J Cardiol. 2025;439:133613.
    PubMed     Abstract available
    
    
    
11. TOGNOLA C, Bernasconi D, Intravaia RCM, Brioschi G, et al
    Prevalence of hypertriglyceridemia and its association with extreme cardiovascular risk in patients with acute and chronic coronary syndrome enrolled in a cardiac rehabilitation program.
    Int J Cardiol. 2025;439:133608.
    PubMed     Abstract available
    
    
    
12. LI F, Zhang JJ, Ruan GJ, Zhan YY, et al
    Prediction models for no-reflow phenomenon after PCI in acute coronary syndrome patients: A systematic review.
    Int J Cardiol. 2025;439:133603.
    PubMed     Abstract available
    
    
    
13. XU X, Liu Z, Liu Z, Li Z, et al
    Increased sympathetic outflow induced by ventromedial hypothalamic nucleus activation aggravates cardiac electrophysiology disturbance after myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2025;439:133634.
    PubMed     Abstract available
    
    
    
14. KATO T, Suzuki K, Kawashima H, Kato Y, et al
    Changes in syndecan-1 concentration in the coronary sinus immediately after cardiac reperfusion reflect postoperative myocardial injury.
    Int J Cardiol. 2025;438:133564.
    PubMed     Abstract available
    
    
    
15. NEBIOLO M, Kang J, Sandrone S, Kim HK, et al
    Duration of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention for bifurcation lesions: Insights from the ULTRA-BIFURCAT registry.
    Int J Cardiol. 2025;438:133542.
    PubMed     Abstract available
    
    
    
16. HU C
    Cangrelor: A new P2Y12 inhibitor with gender differences.
    Int J Cardiol. 2025;438:133511.
    PubMed     Abstract available
    
    
    October 2025
17. ELSCOT JJ, Kakar H, den Dekker WK, Bennett J, et al
    Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome.
    Int J Cardiol. 2025;437:133496.
    PubMed     Abstract available
    
    
    
18. LIU Y, Fu X, Ai X, Li G, et al
    Carotid Intraplaque neovascularization correlates with coronary atherosclerotic plaque, vulnerability detected by intracoronary optical coherence tomography.
    Int J Cardiol. 2025;437:133495.
    PubMed     Abstract available
    
    
    
19. NAMMAS W, Ajosenpaa I, Maaniitty T, Stenstrom I, et al
    Prognostic utility of hybrid coronary computed tomography angiography and myocardial perfusion imaging in elderly patients with suspected coronary artery disease.
    Int J Cardiol. 2025;437:133493.
    PubMed     Abstract available
    
    
    
20. ZENG L, Hu F, Qin P, Jia T, et al
    Dual energy CT-based Radiomics for identification of myocardial focal scar and artificial beam-hardening.
    Int J Cardiol. 2025;437:133482.
    PubMed     Abstract available
    
    
    
21. OLAWADE DB, Soladoye AA, Omodunbi BA, Aderinto N, et al
    Comparative analysis of machine learning models for coronary artery disease prediction with optimized feature selection.
    Int J Cardiol. 2025;436:133443.
    PubMed     Abstract available
    
    
    September 2025
22. POLLER A, Bech-Hanssen O, Redfors B
    Reply to "On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction".
    Int J Cardiol. 2025 Sep 17:133910. doi: 10.1016/j.ijcard.2025.133910.
    PubMed    
    
    
    
23. BICCIRE FG, Di Pietro R, Tu S, Budassi S, et al
    Predictive value of coronary lesion functional assessment using an OCT computational algorithm in the CLIMA study.
    Int J Cardiol. 2025;435:133410.
    PubMed     Abstract available
    
    
    
24. OCANA G, Michaud K, Magnin V, Van der Wal AC, et al
    Coronary CT angiography-derived pericoronary fat attenuation index: Post-mortem histopathological correlation in fatal plaques.
    Int J Cardiol. 2025;435:133388.
    PubMed     Abstract available
    
    
    
25. LINGAMSETTY SSP, Doma M, Kritya M, Thyagaturu H, et al
    Mechanical outcomes of coronary stenting guided by intravascular ultrasound versus optical coherence tomography: A systematic review and meta-analysis with trial sequential analysis of randomized trials.
    Int J Cardiol. 2025;435:133387.
    PubMed     Abstract available
    
    
    
26. KELLER K, Schmitt VH, Hobohm L, Espinola-Klein C, et al
    Risk factors for myocardial infarction in patients with peripheral artery disease.
    Int J Cardiol. 2025 Sep 11:133898. doi: 10.1016/j.ijcard.2025.133898.
    PubMed     Abstract available
    
    
    
27. LENG L, Liu X, Song C, Ran X, et al
    Intra-aortic balloon pump implantation in early-stage cardiogenic shock reduces 30-day mortality in patients with ventricular septal defect following myocardial infarction.
    Int J Cardiol. 2025 Sep 10:133895. doi: 10.1016/j.ijcard.2025.133895.
    PubMed     Abstract available
    
    
    
28. LOPEZ RI, Morello M, Golino M, Hogwood AC, et al
    Interleukin-1 blockade in patients with ST-segment elevation myocardial infarction with and without history of coronary artery disease.
    Int J Cardiol. 2025 Sep 10:133888. doi: 10.1016/j.ijcard.2025.133888.
    PubMed     Abstract available
    
    
    
29. ALFONSO F, Salamanca J, Rivero F
    Cardiogenic shock after acute myocardial infarction: The importance of adherence to management recommendations.
    Int J Cardiol. 2025;442:133860.
    PubMed    
    
    
    
30. MADIAS JE
    On the puzzling speckle tracking echocardiography/clinical severity dissociation between patients with takotsubo syndrome and anterior ST-elevation myocardial infarction.
    Int J Cardiol. 2025 Sep 6:133878. doi: 10.1016/j.ijcard.2025.133878.
    PubMed    
    
    
    
31. ZHANG X, Jin Q, Li C, Yang J, et al
    Prognostic value of angiography-derived microcirculatory resistance in patients undergoing rotational atherectomy- a multi-center study.
    Int J Cardiol. 2025;434:133322.
    PubMed     Abstract available
    
    
    August 2025
32. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 22:133812. doi: 10.1016/j.ijcard.2025.133812.
    PubMed    
    
    
    
33. TIAN J, Wang Y
    Could interleukin-1 receptor antagonist be a reliable predictor of prognosis in acute myocardial infarction?
    Int J Cardiol. 2025 Aug 21:133811. doi: 10.1016/j.ijcard.2025.133811.
    PubMed    
    
    
    
34. POLLER A, Bech-Hanssen O, Redfors B
    Reply to comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
    Int J Cardiol. 2025 Aug 20:133801. doi: 10.1016/j.ijcard.2025.133801.
    PubMed    
    
    
    
35. NILSEN DWT, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients.
    Int J Cardiol. 2025 Aug 19:133807. doi: 10.1016/j.ijcard.2025.133807.
    PubMed    
    
    
    
36. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
    Reply to comment on associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
    Int J Cardiol. 2025 Aug 17:133800. doi: 10.1016/j.ijcard.2025.133800.
    PubMed    
    
    
    
37. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    Reply to: Reinterpreting interleukin-1 receptor antagonist elevation in acute myocardial infarction.
    Int J Cardiol. 2025 Aug 17:133797. doi: 10.1016/j.ijcard.2025.133797.
    PubMed    
    
    
    
38. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    PubMed     Abstract available
    
    
    
39. CHEN J, Yang K
    Comment on "Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction" by Poller et al.
    Int J Cardiol. 2025 Aug 9:133760. doi: 10.1016/j.ijcard.2025.133760.
    PubMed    
    
    
    
40. ZHU B, Xu Y
    Letter to "Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM)".
    Int J Cardiol. 2025 Aug 8:133724. doi: 10.1016/j.ijcard.2025.133724.
    PubMed    
    
    
    
41. ZOU JH, Wang HW, Long JZ, Yang XN, et al
    Unveiling the diagnostic and causal role of hyperlipidemia- and lipophagy-associated genes PLAUR, IVNS1ABP, and QKI in acute myocardial infarction.
    Int J Cardiol. 2025 Aug 7:133635. doi: 10.1016/j.ijcard.2025.133635.
    PubMed     Abstract available
    
    
    
42. BIRTOLO LI, Lattanzio A, Di Pietro G
    Editorial of "Real world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction" to International Journal of Cardiology.
    Int J Cardiol. 2025;440:133705.
    PubMed    
    
    
    
43. XIE P, Wang H, Xiao J, Xu F, et al
    Generative AI-powered explainable prediction model: Enhancing early in-hospital mortality alert for patients with acute myocardial infarction.
    Int J Cardiol. 2025 Aug 5:133649. doi: 10.1016/j.ijcard.2025.133649.
    PubMed     Abstract available
    
    
    
44. ZHAO J, Peng Y
    Letter to the editor: High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
    Int J Cardiol. 2025 Aug 5:133719. doi: 10.1016/j.ijcard.2025.133719.
    PubMed    
    
    
    
45. MORONI F, Golino M, Abbate A
    Unopposed inflammation and long-term outcomes after acute myocardial infarction.
    Int J Cardiol. 2025 Aug 4:133710. doi: 10.1016/j.ijcard.2025.133710.
    PubMed    
    
    
    
46. YANG Y, Jiao X, Shi J
    Moderate-to-vigorous physical activity and sedentary behavior dynamics in coronary heart disease: modifiable targets or mere risk indicators?
    Int J Cardiol. 2025 Aug 2:133714. doi: 10.1016/j.ijcard.2025.133714.
    PubMed    
    
    
    
47. ESMEL-VILOMARA R, Riaza L, Dolader P, Rodriguez-Santiago B, et al
    Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up.
    Int J Cardiol. 2025;432:133255.
    PubMed     Abstract available
    
    
    July 2025
48. LI L, Tang S, Li Y, Zhou X, et al
    Reply to letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025;440:133693.
    PubMed    
    
    
    
49. LIU Y, Li C, Wang L, Hao X, et al
    Report on the adherence to key management strategies and mortality rates in patients with acute myocardial infarction-related cardiogenic shock: Finding from the improving Care for Cardiovascular Disease in China-acute coronary syndrome project.
    Int J Cardiol. 2025 Jul 26:133666. doi: 10.1016/j.ijcard.2025.133666.
    PubMed     Abstract available
    
    
    
50. DWT N, Leon De La Fuente R, Gallo P, Naesgaard P, et al
    High admission levels of interleukin-1 receptor antagonist in acute myocardial infarction patients are associated with increased rates of all-cause mortality and cardiac death at five years follow-up.
    Int J Cardiol. 2025;439:133674.
    PubMed     Abstract available
    
    
    
51. POLLER A, Jha S, Molander L, Espinosa AS, et al
    Global and segmental longitudinal and radial strain in Takotsubo versus ST-elevation myocardial infarction.
    Int J Cardiol. 2025;439:133668.
    PubMed     Abstract available
    
    
    
52. YAO Y, Wu Y
    Letter to the editor: Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025 Jul 21:133657. doi: 10.1016/j.ijcard.2025.133657.
    PubMed    
    
    
    
53. SUN R, Li L
    The comment on "Associations between changes in moderate-to-vigorous physical activity and sedentary behaviour with recurrent cardiovascular events among individuals with coronary heart disease".
    Int J Cardiol. 2025 Jul 16:133631. doi: 10.1016/j.ijcard.2025.133631.
    PubMed    
    
    
    
54. SU X, Qiu M, Liu H, Xu K, et al
    Prolonged dual antiplatelet therapy strategy in acute coronary syndrome patients post-standard therapy and adverse event-free: An analysis based on OPT-CAD risk score stratification.
    Int J Cardiol. 2025;439:133636.
    PubMed     Abstract available
    
    
    
55. DE GREGORIO C, Granata L, Raspanti D, Giannino F, et al
    Cephalosporin triggered Kounis syndrome: Pathophysiological and clinical insights.
    Int J Cardiol. 2025;431:133249.
    PubMed     Abstract available
    
    
    
56. LAMMENS J, Motoc A, Tanaka K, Belsack D, et al
    Favorable impact of FFR(CT) on myocardial revascularization outcomes: Results from an observational real-world registry.
    Int J Cardiol. 2025;431:133245.
    PubMed     Abstract available
    
    
    
57. KUHN L, Akin I, Steinke P, Abumayyaleh M, et al
    Obesity is associated with impaired long-term prognosis in patients undergoing coronary angiography: Results from a large-scaled single centre registry.
    Int J Cardiol. 2025;431:133252.
    PubMed     Abstract available
    
    
    
58. YAMAMOTO K, Saito Y, Tateishi K, Kato K, et al
    Relation between previously implanted coronary stents and vasospasm: Patient- and vessel-level analysis.
    Int J Cardiol. 2025;431:133248.
    PubMed     Abstract available
    
    
    
59. LI Z, Huang S, Li H, Liu Q, et al
    PERK's novel agonist protects against myocardial ischemia-reperfusion injury by modulating ER-mitochondria contacts and phosphatidic acid transport.
    Int J Cardiol. 2025;431:133222.
    PubMed     Abstract available
    
    
    
60. LIU T, Fan Z, Li Y, Xiao B, et al
    Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study.
    Int J Cardiol. 2025;431:133229.
    PubMed     Abstract available
    
    
    
61. WANG J, Li C, Zhang M, Zhou J, et al
    The performance of angiography-derived index of microcirculatory resistance for ischemia in angina with non-obstructive coronary artery disease: Validated by wire-based IMR and SPECT-MPI.
    Int J Cardiol. 2025;431:133236.
    PubMed     Abstract available
    
    
    
62. ZHU Y, Wang X, Su S, Qiao Z, et al
    Interpretable hybrid-ensemble acute myocardial infarction diagnosis with clinical transparency.
    Int J Cardiol. 2025 Jul 5:133598. doi: 10.1016/j.ijcard.2025.133598.
    PubMed     Abstract available
    
    
    
63. TANG S, Li L, Chen H, Geru A, et al
    Real-world comparative effectiveness of angiotensin-neprilysin inhibition versus angiotensin receptor blockers in acute myocardial infarction.
    Int J Cardiol. 2025 Jul 3:133543. doi: 10.1016/j.ijcard.2025.133543.
    PubMed     Abstract available
    
    
    
64. YINHUA L, Hu Y, Ziyue Z, Zhou J, et al
    Systemic coagulation-inflammation index in the prediction of ISR in patients undergoing drug-eluting stents implant: A retrospective study based on multiple machine learning methods.
    Int J Cardiol. 2025;430:133215.
    PubMed     Abstract available
    
    
    
65. NAMBA HF, Boerhout CKM, Damman P, Kunadian V, et al
    Invasive coronary function testing in clinical practice: Implementing the 2024 ESC guidelines on chronic coronary syndromes.
    Int J Cardiol. 2025;430:133176.
    PubMed     Abstract available
    
    
    
66. FAN C, Yan H, Lei K, Li D, et al
    Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project.
    Int J Cardiol. 2025;430:133184.
    PubMed     Abstract available
    
    
    
67. TSAI TY, Revaiah PC, Aldujeli A, Miyashita K, et al
    Cumulative plaque burden analysis for phenotyping epicardial coronary artery disease.
    Int J Cardiol. 2025;430:133173.
    PubMed     Abstract available
    
    
    June 2025
68. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
    Reply to "Growth differentiation factor 15 and empagliflozin in acute myocardial infarction: Correspondence".
    Int J Cardiol. 2025;438:133531.
    PubMed    
    
    
    
69. CHEN L, Ge L, Abdu FA, Du X, et al
    Prognostic value of CMR-derived extracellular volume in myocardial infarction with non-obstructive coronary arteries.
    Int J Cardiol. 2025;437:133528.
    PubMed     Abstract available
    
    
    
70. ZHANG X, Jin Q, Xue Q
    Reply to: Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
    Int J Cardiol. 2025;437:133490.
    PubMed    
    
    
    
71. GUARNIERI G, Pozzi FE, Conte E, Righetto M, et al
    Extreme endurance training and coronary artery disease: A systematic review and a meta-analysis.
    Int J Cardiol. 2025;429:133172.
    PubMed     Abstract available
    
    
    
72. BERRY C, Camici PG, Crea F, George M, et al
    Clinical standards in angina and non-obstructive coronary arteries: A clinician and patient consensus statement.
    Int J Cardiol. 2025;429:133162.
    PubMed     Abstract available
    
    
    
73. LONN A, Carroll SJ, Niyonsenga T, Bauman A, et al
    Associations between change in moderate-to-vigorous physical activity and sedentary behaviour with risk of recurrent cardiovascular events among individuals with coronary heart disease: A prospective cohort study.
    Int J Cardiol. 2025;437:133513.
    PubMed     Abstract available
    
    
    
74. SMARZ K, Tysarowski M
    Response to comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
    Int J Cardiol. 2025;437:133484.
    PubMed    
    
    
    
75. BIASIN M, Cordioli N, Armani I, Guerrieri L, et al
    Lipid profiles in ST-elevation myocardial infarction with and without diabetes: the gap between prescription and targets.
    Int J Cardiol. 2025;437:133474.
    PubMed     Abstract available
    
    
    
76. HAN J, Wang Z, Chen T, Liu S, et al
    Artificial intelligence driven plaque characterization and functional assessment from CCTA using OCT-based automation: A prospective study.
    Int J Cardiol. 2025;428:133140.
    PubMed     Abstract available
    
    
    
77. KUNA C, Bradaric C, Koch T, Presch A, et al
    Age-related ten-year outcomes after percutaneous coronary intervention of in-stent restenosis.
    Int J Cardiol. 2025;428:133109.
    PubMed     Abstract available
    
    
    May 2025
78. GRIFFITH GJ
    Chronotropic incompetence and the importance of cardiopulmonary exercise testing following myocardial infarction.
    Int J Cardiol. 2025 May 31:133445. doi: 10.1016/j.ijcard.2025.133445.
    PubMed    
    
    
    
79. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
    The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025;436:133429.
    PubMed    
    
    
    
80. AHMAD MH, Bilal M, Ibrahim M, Iman H, et al
    Letter to editor on low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025 May 27:133432. doi: 10.1016/j.ijcard.2025.133432.
    PubMed    
    
    
    
81. GIALLAURIA F, Vigorito C
    Editorial to "Impact of Frailty Assessment on Outcomes in Critical Acute Myocardial Infarction: Insights from the Hospital Frailty Risk Measure (HFRM)", Wu et al., Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294. Epub ahead of pri
    Int J Cardiol. 2025;435:133418.
    PubMed    
    
    
    
82. FERRI N
    "SES", "SESS", or "SVESS" approaches for patients with myocardial infarction.
    Int J Cardiol. 2025;435:133412.
    PubMed    
    
    
    
83. LAMELAS P, Sa MP, Izcovich A, Bottaro F, et al
    Percutaneous or surgical revascularization in patients with severe left main coronary artery disease in Latin America: A GRADE clinical practice guideline.
    Int J Cardiol. 2025 May 20:133401. doi: 10.1016/j.ijcard.2025.133401.
    PubMed     Abstract available
    
    
    
84. FROYSA V, Berg GJ, Singsaas E, Eftestol T, et al
    Texture-based probability mapping for automatic assessment of myocardial injury in late gadolinium enhancement images after revascularized STEMI.
    Int J Cardiol. 2025;427:133107.
    PubMed     Abstract available
    
    
    
85. DZIEWIERZ A
    Interplay between angiography-derived microcirculatory resistance and periprocedural myocardial infarction following rotational atherectomy.
    Int J Cardiol. 2025;435:133395.
    PubMed    
    
    
    
86. HAIDER A, Imran A
    Comment on "Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction".
    Int J Cardiol. 2025;435:133394.
    PubMed    
    
    
    
87. ZARRAR M
    Growth Differentiation Factor 15 and Empagliflozin in acute myocardial infarction: Correspondence.
    Int J Cardiol. 2025 May 11:133365. doi: 10.1016/j.ijcard.2025.133365.
    PubMed    
    
    
    
88. PETERS EJ, Henriques JPS
    Response to the Letter to the Editor on "Sex disparities in myocardial infarction related cardiogenic shock".
    Int J Cardiol. 2025 May 3:133311. doi: 10.1016/j.ijcard.2025.133311.
    PubMed    
    
    
    
89. GUPTA R, Yadav O, Gupta N, Yadav A, et al
    Re: Use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025;434:133355.
    PubMed    
    
    
    
90. STEITIEH D, Beale R, Katznelson E, Feldman E, et al
    Trends in mechanical circulatory support utilization, left ventricular assist device implantation and transplant during cardiogenic shock hospitalizations, after the new heart allocation policy.
    Int J Cardiol. 2025;426:133054.
    PubMed     Abstract available
    
    
    April 2025
91. PATTI G, Cumitini L, Bosco M, Marengo A, et al
    Impact of a personalized, strike early and strong approach on non-HDL-cholesterol levels and outcome in patients with acute myocardial infarction.
    Int J Cardiol. 2025 Apr 29:133327. doi: 10.1016/j.ijcard.2025.133327.
    PubMed     Abstract available
    
    
    
92. SMARZ K, Tysarowski M, Ziolo J, Zaborska B, et al
    Low chronotropic response in post-myocardial infarction exercise test predicts worse prognosis in patients with preserved or mildly reduced left ventricular ejection fraction.
    Int J Cardiol. 2025;433:133320.
    PubMed     Abstract available
    
    
    
93. WU S, Xu W, Hao B, Lin Z, et al
    Impact of frailty assessment on outcomes in critical acute myocardial infarction: Insights from the hospital frailty risk measure (HFRM).
    Int J Cardiol. 2025 Apr 22:133294. doi: 10.1016/j.ijcard.2025.133294.
    PubMed     Abstract available
    
    
    
94. ABUSNINA W, Chaturvedi A, Chitturi KR, Lupu L, et al
    Gender disparities in cangrelor usage for the treatment of patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Int J Cardiol. 2025 Apr 12:133280. doi: 10.1016/j.ijcard.2025.133280.
    PubMed     Abstract available
    
    
    
95. RAZAVI SR, Szun T, Zaremba AC, Cheung S, et al
    Predicting prolonged length of in-hospital stay in patients with non-ST elevation myocardial infarction (NSTEMI) using artificial intelligence.
    Int J Cardiol. 2025;432:133267.
    PubMed     Abstract available
    
    
    
96. CARLSON PE, Schwager S, Feldewerd K, Schmidt S, et al
    The use of supersaturated oxygen therapy in patients with late-presentation anterior ST-segment elevation myocardial infarction.
    Int J Cardiol. 2025 Apr 8:133256. doi: 10.1016/j.ijcard.2025.133256.
    PubMed     Abstract available
    
    
    
97. CILIBERTI G, Fortuni F, Santucci A, Timi A, et al
    Temporal trends of characteristics and management of patients with suspected MINOCA.
    Int J Cardiol. 2025;424:133039.
    PubMed     Abstract available
    
    
    March 2025
98. HASAN M, Chola MH
    Comment on"Sex disparities in myocardial infarction related cardiogenic shock".
    Int J Cardiol. 2025;430:133209.
    PubMed    
    
    
    
99. YANG X, Wu H, Liu D, Zhou G, et al
    Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction.
    Int J Cardiol. 2025;430:133189.
    PubMed    
    
    
    
100. OLIVERI F, van Oort MJH, Phagu AAS, Al Amri I, et al
     Intravascular lithotripsy in calcified left main coronary artery: Procedural success and 1-year clinical outcomes.
     Int J Cardiol. 2025;423:132996.
     PubMed     Abstract available
     
     
     
101. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
     Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?
     Int J Cardiol. 2025;429:133167.
     PubMed     Abstract available
     
     
     
102. BILQUEES A, Saleem D, Aamir M
     Constructive feedback on the link between depression and acute myocardial infarction: A response to recent findings.
     Int J Cardiol. 2025;429:133156.
     PubMed    
     
     
     
103. SAITO Y, Kobayashi Y
     Endeavor of exploring mechanisms of myocardial infarction in patients with no standard modifiable cardiovascular risk factors.
     Int J Cardiol. 2025;429:133155.
     PubMed    
     
     
     
104. ROULE V, Singh M, Trimaille A, Delmas C, et al
     Prevalence of recreational drug use in myocardial infarction patients without standard modifiable risk factors: Insights from a multicenter prospective cohort study.
     Int J Cardiol. 2025 Mar 10:133146. doi: 10.1016/j.ijcard.2025.133146.
     PubMed     Abstract available
     
     
     
105. SIRAW BB, Isha S, Mehadi AY, Tafesse YT, et al
     In-hospital outcomes of cardiogenic shock patients: A propensity score-matched nationwide comparative analysis between intra-aortic balloon pump and percutaneous ventricular assist devices.
     Int J Cardiol. 2025 Mar 3:133093. doi: 10.1016/j.ijcard.2025.133093.
     PubMed     Abstract available
     
     
     
106. GALANTE D, Vicere A, Marrone A, Verardi FM, et al
     Fractional flow reserve (FFR) and index of microcirculatory resistance (IMR) relationship in patients with chronic or stabilized acute coronary syndromes.
     Int J Cardiol. 2025;422:132978.
     PubMed     Abstract available
     
     
     
107. ZHANG M, Chen Q, Cheng K, Zhang W, et al
     Long non-coding RNA XR008038 promotes the myocardial ischemia/reperfusion injury development through increasing the expressions of galectin-3.
     Int J Cardiol. 2025;422:132955.
     PubMed     Abstract available
     
     
     
108. XU J, Luo D, Lei Y, Hu Z, et al
     Correlation between abnormal microvascular perfusion and quantitative flow ratio after primary PCI in patients with STEMI.
     Int J Cardiol. 2025;422:132949.
     PubMed     Abstract available
     
     
     
109. MANDURINO-MIRIZZI A, Munafo AR, Rizzo F, Raone L, et al
     Comparison of different guidance strategies to percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
     Int J Cardiol. 2025;422:132936.
     PubMed     Abstract available
     
     
     February 2025
110. YI L, Quan W, Zhang M, Zhu T, et al
     Corrigendum to "Potential of(68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction" [International journal of cardiology vol. 414 (2024): 132425].
     Int J Cardiol. 2025;426:133086.
     PubMed    
     
     
     
111. NISHI T, Saito Y, Tateishi K, Kobayashi Y, et al
     Safety and clinical implications of coronary spasm provocation testing in patients presenting with myocardial infarction with no overt culprit lesion.
     Int J Cardiol. 2025 Feb 20:133066. doi: 10.1016/j.ijcard.2025.133066.
     PubMed     Abstract available
     
     
     
112. RICKEN KWLM, Lipsic E
     Reply to: Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Feb 18:133071. doi: 10.1016/j.ijcard.2025.133071.
     PubMed    
     
     
     
113. YANG Y, Yan Y, Zhou Z, Zhang J, et al
     Accurate prediction of bleeding risk after coronary artery bypass grafting with dual antiplatelet therapy: A machine learning model vs. the PRECISE-DAPT score.
     Int J Cardiol. 2025;421:132925.
     PubMed     Abstract available
     
     
     
114. PETERSON BE, Bhatt DL, Ballantyne CM, de Lemos JA, et al
     Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: Insights from the GOULD registry.
     Int J Cardiol. 2025;421:132916.
     PubMed     Abstract available
     
     
     
115. DENG C, Liu Z, Zhao R, Shi B, et al
     Intravascular imaging and functional assessment for coronary in-stent restenosis: Current status and future directions.
     Int J Cardiol. 2025;421:132918.
     PubMed     Abstract available
     
     
     
116. OZAKI R, Motoyama S, Ozaki Y, Sarai M, et al
     Impact of CT-angiography derived plaque characteristics on cardiac events in patients with a negative invasive fractional flow reserve.
     Int J Cardiol. 2025;421:132895.
     PubMed     Abstract available
     
     
     
117. KUBICA J, Adamski P, Ostrowska M, Kubica A, et al
     Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.
     Int J Cardiol. 2025;421:132897.
     PubMed     Abstract available
     
     
     
118. DEMIREL C, Hamzaraj K, Fangl J, Hemetsberger R, et al
     Association of ABO blood group with risk of coronary stent thrombosis.
     Int J Cardiol. 2025;421:132758.
     PubMed     Abstract available
     
     
     
119. MAURINA M, Riche M, Oliva O, Zendjebil S, et al
     Decoding medina 0.0.1 bifurcation: Are all codes equal? Results from a multicentric registry.
     Int J Cardiol. 2025;421:132863.
     PubMed     Abstract available
     
     
     
120. SHAIKH S, Hamza M, Neppala S, Singh S, et al
     Colchicine for secondary prevention in patients with acute coronary syndrome: A systematic review and meta-analysis.
     Int J Cardiol. 2025 Feb 7:133045. doi: 10.1016/j.ijcard.2025.133045.
     PubMed     Abstract available
     
     
     
121. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
     Retraction notice to "Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The Perfect-CR study?" [International journal of Cardiology 371C (2022) 40-48].
     Int J Cardiol. 2025;420:132876.
     PubMed    
     
     
     
122. KRAVCHENKO D, Vecsey-Nagy M, Varga-Szemes A, Hagar MT, et al
     Intra-individual radiomic analysis of pericoronary adipose tissue: Photon-counting detector vs energy-integrating detector CT angiography.
     Int J Cardiol. 2025;420:132749.
     PubMed     Abstract available
     
     
     January 2025
123. MO SF, Zeng QP, Yang L
     Left atrial strain: A newly emerging prognostic marker for ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Jan 31:133034. doi: 10.1016/j.ijcard.2025.133034.
     PubMed    
     
     
     
124. DE SIO V, Gragnano F, Capolongo A, Guarnaccia N, et al
     Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome.
     Int J Cardiol. 2025;423:133028.
     PubMed     Abstract available
     
     
     
125. WANG L, Wu H, Wu C, Shu L, et al
     A deep-learning system integrating electrocardiograms and laboratory indicators for diagnosing acute aortic dissection and acute myocardial infarction.
     Int J Cardiol. 2025 Jan 27:133008. doi: 10.1016/j.ijcard.2025.133008.
     PubMed     Abstract available
     
     
     
126. SAITO T, Watanabe A, Aikawa T, Kapur NK, et al
     Comparison of temporary mechanical circulatory support devices for patients with cardiogenic shock after acute myocardial infarction: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2025 Jan 25:132997. doi: 10.1016/j.ijcard.2025.132997.
     PubMed     Abstract available
     
     
     
127. CHEN Y, Fang C, Zhao J, Jiang S, et al
     Glycemic control and coronary plaque characteristics in patients with acute myocardial infarction.
     Int J Cardiol. 2025;423:132988.
     PubMed     Abstract available
     
     
     
128. KWOK CS, Borovac JA, Will M, Schwarz K, et al
     Hospitalizations during the 30-day period preceding the admission for the acute ST-elevation myocardial infarction: Insights from the Nationwide Readmission Database (NRD).
     Int J Cardiol. 2025 Jan 16:132991. doi: 10.1016/j.ijcard.2025.132991.
     PubMed     Abstract available
     
     
     
129. BERNTORP K, Mohammad MA, Koul S, Yndigegn T, et al
     Deferral of left main coronary artery revascularization via IVUS or coronary physiology - Long-term outcomes from the SWEDEHEART registry.
     Int J Cardiol. 2025;419:132726.
     PubMed     Abstract available
     
     
     
130. GIGANTE B, Chen Q, Bjorkbacka H, Bjornson E, et al
     Lipoproteins and lipoprotein lipid composition are associated with stages of dysglycemia and subclinical coronary atherosclerosis.
     Int J Cardiol. 2025;419:132698.
     PubMed     Abstract available
     
     
     
131. SCHAUFELE T, Nobre Menezes M, Schulte Steinberg B, Hubert A, et al
     Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing.
     Int J Cardiol. 2025;419:132703.
     PubMed     Abstract available
     
     
     
132. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
     Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
     Int J Cardiol. 2025;419:132694.
     PubMed     Abstract available
     
     
     
133. URIBARRI A, Vazirani R, Delia MA, Tomasino M, et al
     Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry.
     Int J Cardiol. 2025;419:132681.
     PubMed     Abstract available
     
     
     
134. HE P, Chen H, Yang J, Gao L, et al
     The efficacy of an intracoronary cocktail administration in preventing no-reflow during excimer laser coronary angioplasty in patients with in-stent restenosis: A pilot study. (ELCA- cocktail study).
     Int J Cardiol. 2025;419:132666.
     PubMed     Abstract available
     
     
     
135. MOLEDINA SM, Weight N, Cole A, Rashid M, et al
     The impact of specialist cardiology inpatient care on the long-term outcomes of non-ST-segment elevation myocardial infarction (NSTEMI): A nationwide cohort study.
     Int J Cardiol. 2025 Jan 15:132990. doi: 10.1016/j.ijcard.2025.132990.
     PubMed     Abstract available
     
     
     
136. BAUER D, Spanyi SB, Neuberg M, Kocka V, et al
     Myocardial infarction in multivessel disease: Does presence of chronic total occlusion make a difference?
     Int J Cardiol. 2025 Jan 12:132984. doi: 10.1016/j.ijcard.2025.132984.
     PubMed     Abstract available
     
     
     
137. KESTI H, Mattila K, Jaakkola S, Lehto J, et al
     Impact of high bleeding risk and associated risk factors on major adverse cardiovascular or cerebrovascular events in primary percutaneous coronary intervention treated ST-elevation myocardial infarction.
     Int J Cardiol. 2025 Jan 11:132986. doi: 10.1016/j.ijcard.2025.132986.
     PubMed     Abstract available
     
     
     
138. HAKIM D, Ahmed M, Coskun AU, Maynard C, et al
     Spatial patterns of high-risk biomechanical metrics in plaques with abnormal vs. normal physiological flow indices.
     Int J Cardiol. 2025;418:132651.
     PubMed     Abstract available
     
     
     
139. DE JONG EAM, Namba HF, Boerhout CKM, Feenstra RGT, et al
     Assessment of coronary endothelial dysfunction using contemporary coronary function testing.
     Int J Cardiol. 2025;418:132640.
     PubMed     Abstract available
     
     
     
140. NAMBA HF, Boerhout CKM, de Jong EAM, van de Hoef TP, et al
     Aortic versus distal pressure for derivation of hyperaemic microvascular resistance: From the ILIAS registry.
     Int J Cardiol. 2025;418:132632.
     PubMed     Abstract available
     
     
     
141. WOXHOLT S, Ueland T, Aukrust P, Anstensrud AK, et al
     Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI.
     Int J Cardiol. 2025;418:132613.
     PubMed     Abstract available
     
     
     
142. CAHUAPAZA-GUTIERREZ NL, Calderon-Hernandez CC, Chambergo-Michilot D, De Arruda-Chaves E, et al
     Clinical characteristics, management, diagnostic findings, and various etiologies of patients with Kounis syndrome. A systematic review.
     Int J Cardiol. 2025;418:132606.
     PubMed     Abstract available
     
     
     
143. MAHENDIRAN T, Thanou D, Senouf O, Jamaa Y, et al
     AngioPy Segmentation: An open-source, user-guided deep learning tool for coronary artery segmentation.
     Int J Cardiol. 2025;418:132598.
     PubMed     Abstract available
     
     
     
144. GOYAL A, Tariq MD, Shahnoor S, Saeed H, et al
     Short- and long-term outcomes of antegrade versus retrograde approaches in patients undergoing percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
     Int J Cardiol. 2025;418:132590.
     PubMed     Abstract available
     
     
     December 2024
145. STANISLAWSKI R, Aboul-Hassan SS, Pieszko K, Awad AK, et al
     Long-term outcomes of minimally invasive direct coronary artery bypass vs second generation drug eluting stent for management of isolated left anterior descending artery disease.
     Int J Cardiol. 2024;422:132935.
     PubMed     Abstract available
     
     
     
146. FATH AR, Elgendy IY
     Steps towards closing the sex-related disparities in acute myocardial infarction-related cardiogenic shock.
     Int J Cardiol. 2024 Dec 24:132928. doi: 10.1016/j.ijcard.2024.132928.
     PubMed    
     
     
     
147. RICKEN KWLM, Lenselink C, Venema CS, van der Horst ICC, et al
     Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Dec 22:132931. doi: 10.1016/j.ijcard.2024.132931.
     PubMed     Abstract available
     
     
     
148. KATAMINE M, Minami Y, Nagata T, Asakura K, et al
     High-sensitivity C-reactive protein, plaque vulnerability and adverse events in patients with stable coronary disease: An optical coherence tomography study.
     Int J Cardiol. 2024;421:132924.
     PubMed     Abstract available
     
     
     
149. TINDALE A, Elghazaly H, Baker C, Panoulas V, et al
     External validation of the BE-ALIVE score for predicting 30-day mortality in patients presenting with acute coronary syndromes.
     Int J Cardiol. 2024;417:132560.
     PubMed     Abstract available
     
     
     
150. LOUTATI R, Bruoha S, Taha L, Karmi M, et al
     Association between peak troponin level and prognosis among patients admitted to intensive cardiovascular care unit.
     Int J Cardiol. 2024;417:132556.
     PubMed     Abstract available
     
     
     
151. CHO S, Cho H, Min H, Lee JG, et al
     Clinical impact of deep learning-derived intravascular ultrasound characteristics in patients with deferred coronary artery.
     Int J Cardiol. 2024;417:132543.
     PubMed     Abstract available
     
     
     
152. IMPROTA R, Di Pietro G, Piccialuti A, De Filippo O, et al
     Invasive and conservative management of elderly patients presenting with acute coronary syndrome: A meta-analysis of randomized controlled trials and adjusted observational studies.
     Int J Cardiol. 2024;417:132523.
     PubMed     Abstract available
     
     
     
153. WATANABE A, Miyamoto Y, Ueyama H, Gotanda H, et al
     The use of pulmonary artery catheter and clinical outcomes in older adults with cardiogenic shock.
     Int J Cardiol. 2024;417:132509.
     PubMed     Abstract available
     
     
     
154. SUNDQVIST MO, Svensson P, Soderberg S, Bergdahl IA, et al
     Seroprevalence of Helicobacter pylori and incident myocardial infarction - A population-based Swedish nested case-control study.
     Int J Cardiol. 2024 Dec 15:132917. doi: 10.1016/j.ijcard.2024.132917.
     PubMed     Abstract available
     
     
     
155. SIA CH, Ho AFW
     Cardiogenic shock in the setting of acute myocardial infarction: Still a difficult entity to treat.
     Int J Cardiol. 2024;421:132886.
     PubMed    
     
     
     
156. QIAN L, Zhang S, Lin C, Lin J, et al
     Depression exacerbates myocardial ischemia-reperfusion injury in mice via CNR2 gene and MIF-AMPK signaling pathway.
     Int J Cardiol. 2024;416:132505.
     PubMed     Abstract available
     
     
     
157. TEIXEIRA L, Ferreira ROM, Navalha DDP, Pasqualotto E, et al
     Intravascular imaging-guided vs. angiography-guided percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials in high-risk patients and complex coronary anatomies.
     Int J Cardiol. 2024;416:132510.
     PubMed     Abstract available
     
     
     
158. LIU Y, Huang M, Dai W
     Letter to the editor: Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
     Int J Cardiol. 2024;416:132501.
     PubMed    
     
     
     
159. MONARES-ZEPEDA E, Barrera-Hoffmann C, Cueto-Robledo G, Navarro-Vergara DI, et al
     Mechanical power in cardiogenic shock.
     Int J Cardiol. 2024;416:132499.
     PubMed    
     
     
     
160. WU Y, Lin Y, Liu B, Ma J, et al
     Shexiang Tongxin dropping pill ameliorates microvascular obstruction via downregulating ALOX12 after myocardial ischemia-reperfusion.
     Int J Cardiol. 2024;416:132481.
     PubMed     Abstract available
     
     
     
161. ZHANG W, Zhang W, Deng Y, Gu N, et al
     Non-target lesion progression: Unveiling critical predictors and outcomes in patients with in-stent restenosis.
     Int J Cardiol. 2024;416:132451.
     PubMed     Abstract available
     
     
     November 2024
162. FEZZI S, Pesarini G, Flaim M, Ding D, et al
     Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
     Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
     PubMed     Abstract available
     
     
     
163. ALEKSOVA A, Fluca AL, Janjusevic M, Padoan L, et al
     Differences between MINOCA and type 2 myocardial infarction: An ITALIAN observational study.
     Int J Cardiol. 2024 Nov 24:132745. doi: 10.1016/j.ijcard.2024.132745.
     PubMed     Abstract available
     
     
     
164. ZHU Q, Li X
     Reply to "Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?".
     Int J Cardiol. 2024;415:132471.
     PubMed    
     
     
     
165. VINK CEM, de Jong EAM, Woudstra J, Molenaar M, et al
     The role of myocardial blood volume in the pathophysiology of angina with non-obstructed coronary arteries: The MICORDIS study.
     Int J Cardiol. 2024;415:132479.
     PubMed     Abstract available
     
     
     
166. IWANCZYK S, Lazar FL, Onea HL, Pesenti N, et al
     Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison.
     Int J Cardiol. 2024;415:132436.
     PubMed     Abstract available
     
     
     
167. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
     Temporal trends in ACS outcomes: Balancing technological advances with patient complexity.
     Int J Cardiol. 2024;415:132442.
     PubMed    
     
     
     
168. XIE H, Qiu M, Li X, Xiao Y, et al
     Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
     Int J Cardiol. 2024;415:132450.
     PubMed     Abstract available
     
     
     
169. KINI AS, Garcia H, Springer B, Vengrenyuk A, et al
     A mobile application for STEMI care optimization: Pilot implementation project report.
     Int J Cardiol. 2024;415:132447.
     PubMed     Abstract available
     
     
     
170. LIANG ES, Liu X
     Slamf8: A potential therapeutic target for cardiac ischemia/reperfusion injury.
     Int J Cardiol. 2024;415:132446.
     PubMed    
     
     
     
171. ONG P, Seitz A
     Precision medicine in the treatment of STEMI patients - it's time for coronary physiology!
     Int J Cardiol. 2024;415:132429.
     PubMed    
     
     
     
172. DI VITO L, Di Giusto F, Mazzotta S, Scalone G, et al
     Management of vulnerable patient phenotypes and acute coronary syndrome mechanisms.
     Int J Cardiol. 2024;415:132365.
     PubMed     Abstract available
     
     
     
173. PETERS EJ, Ten Berg S, Bogerd M, Engstrom AE, et al
     Sex disparities in myocardial infarction related cardiogenic shock.
     Int J Cardiol. 2024;420:132730.
     PubMed     Abstract available
     
     
     
174. HOOKANA I, Junttila J
     Reply to the letter "Age-related trends of ischemic sudden cardiac death in women".
     Int J Cardiol. 2024;414:132439.
     PubMed    
     
     
     
175. SHARMA R, Aggarwal G, Kumar A, Thakur AK, et al
     Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach.
     Int J Cardiol. 2024;414:132418.
     PubMed     Abstract available
     
     
     
176. XU W
     Ultrasonic flow ratio to diagnosis the functional significance of coronary stenosis undergoing percutaneous coronary intervention.
     Int J Cardiol. 2024;414:132427.
     PubMed    
     
     
     
177. KOOP Y, Nathoe H, Bots M, Grobbee DE, et al
     Octopus follow-up: 20 year prognosis in patients randomized to on-pump CABG, off-pump CABG or PCI.
     Int J Cardiol. 2024;414:132426.
     PubMed     Abstract available
     
     
     
178. NAKAMURA R, Shiono Y, Honda K, Kunimoto H, et al
     Risk factors for unsuccessful restoration of coronary flow reserve after coronary bypass surgery.
     Int J Cardiol. 2024;414:132419.
     PubMed     Abstract available
     
     
     
179. SAMI SZ
     Letter to the Editor: The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
     Int J Cardiol. 2024;414:132406.
     PubMed    
     
     
     
180. EL-NAGGAR HM, Soliman MG, Demitry SR, Ahmed TAN, et al
     Vitamin-K antagonist versus dual antiplatelet therapy in management of isolated and non-obstructive atherosclerotic coronary artery ectasia.
     Int J Cardiol. 2024;414:132412.
     PubMed     Abstract available
     
     
     
181. REGIS SC, Del Castillo-Rix D, Duque JC, Colombo R, et al
     Evaluating the incidence and risk factors for developing acute tubular necrosis after percutaneous coronary intervention in the management of coronary artery dissection.
     Int J Cardiol. 2024;414:132403.
     PubMed     Abstract available
     
     
     
182. JIANG Y, Wei ZY, Wu YJ, Dou KF, et al
     The impacts of percutaneous coronary intervention to treat chronic total occlusion of right coronary artery on the 5-year prognosis: A single-centered retrospective study.
     Int J Cardiol. 2024;414:132384.
     PubMed     Abstract available
     
     
     October 2024
183. WEIGHT N, Singh S, Moledina S, Mamas MA, et al
     The processes of care and long-term mortality of acute myocardial infarction with cardiogenic shock survivors: A nationwide cohort study.
     Int J Cardiol. 2024 Oct 21:132669. doi: 10.1016/j.ijcard.2024.132669.
     PubMed     Abstract available
     
     
     
184. GRECO A, Scalia L, Laudani C, Spagnolo M, et al
     Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis.
     Int J Cardiol. 2024;418:132660.
     PubMed     Abstract available
     
     
     
185. FANG Y, Huang S, Zhang H, Yu M, et al
     The association between fibrinogen-to-albumin ratio and adverse prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
     Int J Cardiol. 2024 Oct 17:132665. doi: 10.1016/j.ijcard.2024.132665.
     PubMed     Abstract available
     
     
     
186. BAN T, Chang Y, Yu R
     Can IGFBP5 levels predict major adverse cardiac events in hyperglycemic AMI patients?
     Int J Cardiol. 2024;413:132407.
     PubMed    
     
     
     
187. LORCA R, Aparicio A, Gutierrez L, Alvarez-Velasco R, et al
     PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal.
     Int J Cardiol. 2024;413:132402.
     PubMed     Abstract available
     
     
     
188. BIANCHINI E, Basile M, Bianchini F, Zito A, et al
     Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A systematic review and meta-analysis of 182,798 patients.
     Int J Cardiol. 2024;413:132392.
     PubMed     Abstract available
     
     
     
189. MICHAUD K, van der Wal AC
     Age and sex disparities in myocardial ischemia-related deaths at autopsy.
     Int J Cardiol. 2024;413:132362.
     PubMed    
     
     
     
190. IWUAGWU M, Olapoju O, Abolaji M
     Age- related trends of ischemic sudden cardiac death in women.
     Int J Cardiol. 2024;413:132349.
     PubMed    
     
     
     
191. CHUNTA A, Miller RJH
     Uncovering STEMI patient phenotypes using unsupervised machine learning.
     Int J Cardiol. 2024;413:132346.
     PubMed    
     
     
     
192. OLMO RF, Cortez G, Toro MM, Sandin M, et al
     A machine learning algorithm for the identification elevated Lp(a) in patients with, or high-risk of having, coronary heart disease.
     Int J Cardiol. 2024 Oct 2:132612. doi: 10.1016/j.ijcard.2024.132612.
     PubMed     Abstract available
     
     
     
193. DENG C, Liu Z, Li C, Xu G, et al
     Predictive models for cholesterol crystals and plaque vulnerability in acute myocardial infarction: Insights from an optical coherence tomography study.
     Int J Cardiol. 2024 Oct 2:132610. doi: 10.1016/j.ijcard.2024.132610.
     PubMed     Abstract available
     
     
     
194. GUGLIELMO M, Fusini L, Baessato F, Baggiano A, et al
     PROGnostic RolE of strain measurements in stress cardiac MRI in predicting major adverse cardiac events.
     Int J Cardiol. 2024;412:132337.
     PubMed     Abstract available
     
     
     
195. AYAYO SA, Kontopantelis E, Martin GP, Zghebi SS, et al
     Temporal trends of in-hospital mortality and its determinants following percutaneous coronary intervention in patients with acute coronary syndrome in England and Wales: A population-based study between 2006 and 2021.
     Int J Cardiol. 2024;412:132334.
     PubMed     Abstract available
     
     
     
196. WU Z, Liu T, Yang Z, Li Y, et al
     Exploring the path of inflammatory markers as clinical prognostic biomarkers in older NSTEACS patients.
     Int J Cardiol. 2024;412:132309.
     PubMed    
     
     
     
197. WANG YP, Xu XD, Xu X, Zhu L, et al
     Aucubin protects against myocardial ischemia-reperfusion injury via activation of the AKT/STAT3 pathway.
     Int J Cardiol. 2024;412:132311.
     PubMed    
     
     
     
198. ZHANG ZJ
     The need to account for concurrent thrombus aspiration when investigating the adverse impact of post-dilation during percutaneous coronary intervention.
     Int J Cardiol. 2024;412:132296.
     PubMed    
     
     
     
199. KUMAR M, Kumar N, Upreti P, Zaka Haider M, et al
     Drug-eluting stent vs. Balloon angioplasty in patients with in-stent restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
     Int J Cardiol. 2024;412:132269.
     PubMed     Abstract available
     
     
     September 2024
200. DE LUCA L, Maggioni AP, Cavallini C, Leonardi S, et al
     Clinical profile and management of patients with acute myocardial infarction admitted to cardiac care units: The EYESHOT-2 registry.
     Int J Cardiol. 2024;418:132601.
     PubMed     Abstract available
     
     
     
201. ZHANG Q, Zhu T, Mingqiang AO, Chen J, et al
     Correlation between serum levels of circ_0001879 and circ_0004104, coronary microcirculation disorders and prognosis after percutaneous coronary intervention (PCI) in patients with stable coronary heart disease.
     Int J Cardiol. 2024 Sep 18:132559. doi: 10.1016/j.ijcard.2024.132559.
     PubMed     Abstract available
     
     
     
202. PROVENZALE G, Barbieri L, Tumminello G, Carugo S, et al
     Exercise response in post-acute coronary syndrome patients survived to COVID-19 infection.
     Int J Cardiol. 2024;411:132285.
     PubMed     Abstract available
     
     
     
203. TILLER C, Reindl M, Lechner I, Reinstadler SJ, et al
     Circulating progenitor cells: A promising biomarker for coronary collateral formation in CTO?
     Int J Cardiol. 2024;411:132267.
     PubMed    
     
     
     
204. GADAGER BB, Tang LH, Doherty P, Svendsen ML, et al
     Are cardiac rehabilitation pathways influenced by diabetes: A cohort study.
     Int J Cardiol. 2024;411:132275.
     PubMed     Abstract available
     
     
     
205. DI FRANCO A
     Navigating complexity among surgical myocardial revascularization strategies: Endoscopic coronary artery bypass gains support.
     Int J Cardiol. 2024;410:132240.
     PubMed    
     
     
     
206. ABU ARAB T, Sedhom R, Gomaa Y, El Etriby A, et al
     Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients.
     Int J Cardiol. 2024;410:132228.
     PubMed     Abstract available
     
     
     
207. BAHARVAND F, Habibi Roudkenar M, Pourmohammadi-Bejarpasi Z, Najafi-Ghalehlou N, et al
     Safety and efficacy of platelet-derived mitochondrial transplantation in ischaemic heart disease.
     Int J Cardiol. 2024;410:132227.
     PubMed     Abstract available
     
     
     
208. HOOKANA I, Eskuri MAE, Holmstrom L, Vahatalo J, et al
     Age-related trends of ischemic sudden cardiac death in women.
     Int J Cardiol. 2024;410:132238.
     PubMed    
     
     
     
209. ABOAL J, Ramos R, Martin C, Loma-Osorio P, et al
     Evaluation of the ODISEA APP for improving a STEMI regional network.
     Int J Cardiol. 2024;410:132217.
     PubMed     Abstract available
     
     
     
210. ABDELBASIT MS
     How often is emergency coronary artery bypass grafting required during chronic total occlusion coronary intervention?
     Int J Cardiol. 2024;410:132215.
     PubMed    
     
     
     
211. TIERNEY M, Norman S, Al Ahmad J, Hansen T, et al
     A 10-year review of presentation, management and outcomes of STEMI in a high-volume regional tertiary Australian centre.
     Int J Cardiol. 2024;410:132224.
     PubMed     Abstract available
     
     
     
212. REGIS SC, Del Castillo-Rix D, Colombo R
     Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study.
     Int J Cardiol. 2024;410:132200.
     PubMed     Abstract available
     
     
     August 2024
213. YAN M, Fu H, Zhang X, Xu K, et al
     More attention needs to focus on the diabetic cardiomyopathy without coronary artery disease.
     Int J Cardiol. 2024;409:132194.
     PubMed    
     
     
     
214. MENDEL B
     Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females? An editorial comment.
     Int J Cardiol. 2024;409:132193.
     PubMed    
     
     
     
215. GOLD DA, Sandesara PB, Jain V, Gold ME, et al
     N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularization.
     Int J Cardiol. 2024;409:132196.
     PubMed     Abstract available
     
     
     
216. HOSSEINI K, Behnoush AH, Khalaji A, Etemadi A, et al
     Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients.
     Int J Cardiol. 2024;409:132191.
     PubMed     Abstract available
     
     
     
217. BRUNO F, De Filippo O, D'Ascenzo F
     Reply to "Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome" by Sterpetti et al.
     Int J Cardiol. 2024;409:132186.
     PubMed    
     
     
     
218. ROMANOV A, Nikitin N
     Epicardial adipose tissue for atrial arrhythmias prediction in coronary artery disease. Are we close to the gold marker?
     Int J Cardiol. 2024;409:132176.
     PubMed    
     
     
     
219. FERNANDES-SILVA MM, Conti-Pelanda JD, Vosgerau LM, Cunha GSP, et al
     Temporal trends in the contribution of modifiable cardiovascular risk factors to cardiovascular and all-cause mortality in patients undergoing myocardial perfusion imaging in a large city in Brazil.
     Int J Cardiol. 2024;409:132178.
     PubMed     Abstract available
     
     
     
220. FEUCHTNER GM, Lacaita PG, Barbieri F, Deeg J, et al
     Gender differences in the diagnostic efficacy of coronary CTA: Overutilization of coronary CTA in pre- and perimenopausal females?
     Int J Cardiol. 2024;409:132181.
     PubMed     Abstract available
     
     
     
221. SAMPON F, Ter Woorst J, Dekker L, Akca F, et al
     Thoracoscopic-assisted, minimally invasive versus off-pump bypass grafting for single vessel coronary artery disease - A propensity matched analysis.
     Int J Cardiol. 2024;409:132175.
     PubMed     Abstract available
     
     
     
222. FRACASSI F, Animati FM, Cappannoli L, Burzotta F, et al
     Thin-cap fibroatheroma: the trigger of acute coronary syndromes. Pathophysiological and prognostic importance of in-vivo detection.
     Int J Cardiol. 2024;409:132157.
     PubMed    
     
     
     
223. SI X, Hou C, Wang H, Yan W, et al
     Comparison of six Z-score formulas based on echocardiography for coronary artery lesions in Kawasaki disease.
     Int J Cardiol. 2024;409:132102.
     PubMed     Abstract available
     
     
     
224. YI L, Quan W, Zhang M, Zhu T, et al
     Potential of (68)Ga-FAPI-04 PET/MR to predict worsening renal function after acute ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Aug 2:132425. doi: 10.1016/j.ijcard.2024.132425.
     PubMed     Abstract available
     
     
     
225. GHOBRIAL M, Bawamia B, Cartlidge T, Purcell I, et al
     The role of gender in resting full-cycle ratio (RFR) guided coronary revascularization.
     Int J Cardiol. 2024;408:132159.
     PubMed     Abstract available
     
     
     
226. HONGQUAN L, Nina C, Xia Y, Lujiang Z, et al
     BECN1 regulates FADD/RIPK1/Caspase-8 complex formation via RIPK1 ubiquitination by downregulating OTUD1 in MI/R induced myocyte apoptosis.
     Int J Cardiol. 2024;408:132158.
     PubMed     Abstract available
     
     
     
227. LANDI A, Heg D, Frigoli E, Routledge H, et al
     Negative selection bias for women inclusion in a clinical trial.
     Int J Cardiol. 2024;408:132138.
     PubMed     Abstract available
     
     
     
228. ALGHAMMASS M, Arora S
     Navigating complex waters: Revascularization strategies and outcomes in post-CABG patients.
     Int J Cardiol. 2024;408:132120.
     PubMed    
     
     
     July 2024
229. DE FERRARI T, Pistelli L, Franzino M, Molinero AE, et al
     MI2AMI-CS: A meta-analysis comparing Impella and IABP outcomes in acute myocardial infarction-related cardiogenic shock.
     Int J Cardiol. 2024 Jul 31:132411. doi: 10.1016/j.ijcard.2024.132411.
     PubMed     Abstract available
     
     
     
230. TSENG CH
     Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and/or acute coronary syndrome: A neglected clinical scenario and the potential role of insulin.
     Int J Cardiol. 2024 Jul 30:132400. doi: 10.1016/j.ijcard.2024.132400.
     PubMed    
     
     
     
231. LI YY, Chen HR, Yang Y, Pan YJ, et al
     Murine exosomal miR-30a aggravates cardiac function after acute myocardial infarction via regulating cell fate of cardiomyocytes and cardiac resident macrophages.
     Int J Cardiol. 2024 Jul 27:132395. doi: 10.1016/j.ijcard.2024.132395.
     PubMed     Abstract available
     
     
     
232. NAJAFI-GHALEHLOU N, Baharvand F, Pourmohammadi-Bejarpasi Z, Roushandeh AM, et al
     The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
     Int J Cardiol. 2024;413:132408.
     PubMed    
     
     
     
233. DENG L, Xia Q, Zhang L
     Commentary on "Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction".
     Int J Cardiol. 2024;413:132383.
     PubMed    
     
     
     
234. D'ERRIGO P, De Luca L, Rosato S, Giordani B, et al
     Prognostic role of coronary angiography and revascularization in patients firstly admitted for heart failure in Italy.
     Int J Cardiol. 2024 Jul 23:132369. doi: 10.1016/j.ijcard.2024.132369.
     PubMed     Abstract available
     
     
     
235. GOLD DA, Sandesara PB, Kindya B, Gold ME, et al
     Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.
     Int J Cardiol. 2024;407:132104.
     PubMed     Abstract available
     
     
     
236. CANDREVA A, Buongiorno AL, Matter MA, Rizzini ML, et al
     Impact of endothelial shear stress on coronary atherosclerotic plaque progression and composition: A meta-analysis and systematic review.
     Int J Cardiol. 2024;407:132061.
     PubMed     Abstract available
     
     
     
237. GROEN RA, Barbero FL, Fischer SE, van Dijkman PRM, et al
     Coronary artery calcium assessment on non-gated chest CT to optimize pre-operative cardiac screening in liver transplantation.
     Int J Cardiol. 2024;407:132015.
     PubMed     Abstract available
     
     
     
238. SMITH SW, Meyers HP
     ST Elevation is a poor surrogate for acute coronary occlusion. Let's Replace STEMI with Occlusion MI (OMI)!!
     Int J Cardiol. 2024;407:131980.
     PubMed    
     
     
     
239. KOH SJQ, Jiang Y, Lau YH, Yip WLJ, et al
     Optimal door-to-balloon time for primary percutaneous coronary intervention for ST-elevation myocardial infarction.
     Int J Cardiol. 2024;413:132345.
     PubMed     Abstract available
     
     
     
240. ZHANG L, Liu Z, Zeng J, Wu M, et al
     Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
     PubMed     Abstract available
     
     
     
241. LIU S, Qian F, Lu Q, Deng Y, et al
     Association of life's essential 8 with risk of recurrent cardiovascular events among patients with coronary heart disease.
     Int J Cardiol. 2024;412:132318.
     PubMed     Abstract available
     
     
     
242. BASEM M, Bonnesen K, Schmidt M
     Potential of the Danish Comorbidity Index for Acute Myocardial Infarction to discriminate mortality in patients with infective endocarditis.
     Int J Cardiol. 2024 Jul 2:132328. doi: 10.1016/j.ijcard.2024.132328.
     PubMed     Abstract available
     
     
     
243. SIGLE M, Faller W, Heurich D, Zdanyte M, et al
     Machine learning predicts emergency physician specialties from treatment strategies for patients suspected of myocardial infarction.
     Int J Cardiol. 2024 Jul 2:132332. doi: 10.1016/j.ijcard.2024.132332.
     PubMed     Abstract available
     
     
     
244. FUJINO M, Aikawa H, Nakao K, Takagi K, et al
     Comparison of embolic risk in left ventricular thrombus between nonischemic and ischemic cardiomyopathy: A nationwide database analysis.
     Int J Cardiol. 2024 Jul 2:132329. doi: 10.1016/j.ijcard.2024.132329.
     PubMed     Abstract available
     
     
     
245. LEE YJ, Park G, Lee SG, Cho YK, et al
     Predictive value of plaque characteristics for identification of lesions causing ischemia.
     Int J Cardiol. 2024;406:132097.
     PubMed     Abstract available
     
     
     
246. AKSIT E, Kucuk U, Kirilmaz B
     The increasing importance of lipid lowering therapies as a part of the 'first medical contact' in patients with acute coronary syndrome.
     Int J Cardiol. 2024;406:132095.
     PubMed    
     
     
     
247. GASECKA A, Blazejowska E, Pluta K, Gajewska M, et al
     Ticagrelor downregulates the expression of proatherogenic and proinflammatory miR125-b compared to clopidogrel: A randomized, controlled trial.
     Int J Cardiol. 2024;406:132073.
     PubMed     Abstract available
     
     
     
248. MOMMERSTEEG PMC, Lodder P, Aarnoudse W, Magro M, et al
     Psychosocial distress and health status as risk factors for ten-year major adverse cardiac events and mortality in patients with non-obstructive coronary artery disease.
     Int J Cardiol. 2024;406:132062.
     PubMed     Abstract available
     
     
     
249. TILLMANNS J, Weiglein JM, Neuser J, Fraccarollo D, et al
     Circulating soluble fibroblast activation protein (FAP) levels are independent of cardiac and extra-cardiac FAP expression determined by targeted molecular imaging in patients with myocardial FAP activation.
     Int J Cardiol. 2024;406:132044.
     PubMed     Abstract available
     
     
     
250. REN Y, Chen L, Liu J, Wu Y, et al
     Correlation of epicardial adipose tissue and inflammatory indices in patients with STEMI and implications for atrial arrhythmias.
     Int J Cardiol. 2024;406:132016.
     PubMed     Abstract available
     
     
     
251. CHADHA RM
     CT coronary angiography: Is it the new standard in coronary assessment for liver transplant candidates?
     Int J Cardiol. 2024;406:131999.
     PubMed    
     
     
     
252. YAZDANPANAH M, Yazdanpanah N, Chardoli M, Dehghan A, et al
     Role of interleukin 6 signaling pathway in the anti-inflammatory effects of statins on coronary artery disease: Evidence from Mendelian randomization analysis.
     Int J Cardiol. 2024;406:131964.
     PubMed     Abstract available
     
     
     June 2024
253. CORDERO A, Oterino A
     Individualization of prasugrel dose for patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jun 29:132313. doi: 10.1016/j.ijcard.2024.132313.
     PubMed    
     
     
     
254. KUBAT GB
     The importance of platelet-derived mitochondrial transplantation in ischemic heart disease: A clinical study.
     Int J Cardiol. 2024;412:132312.
     PubMed    
     
     
     
255. LIU XH, Zhang L
     Role of anakinra in patients with ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Jun 25:132297. doi: 10.1016/j.ijcard.2024.132297.
     PubMed    
     
     
     
256. JIN Y, Shen L, Ye R, Zhou M, et al
     Development and validation of a novel score for predicting perioperative major adverse cardiovascular events in patients with stable coronary artery disease undergoing noncardiac surgery.
     Int J Cardiol. 2024;405:131982.
     PubMed     Abstract available
     
     
     
257. BEERKENS FJ, Kucuk IT, van Veelen A, de Lind van Wijngaarden RAF, et al
     Native coronary artery or bypass graft percutaneous coronary intervention in patients after previous coronary artery bypass surgery: A large nationwide analysis from the Netherlands Heart Registration.
     Int J Cardiol. 2024;405:131974.
     PubMed     Abstract available
     
     
     
258. LI C, Deng C, Shi B, Zhao R, et al
     Thin-cap fibroatheroma in acute coronary syndrome: Implication for intravascular imaging assessment.
     Int J Cardiol. 2024;405:131965.
     PubMed     Abstract available
     
     
     
259. IN KIM Y, Roh JH, Kweon J, Kwon H, et al
     Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning.
     Int J Cardiol. 2024;405:131945.
     PubMed     Abstract available
     
     
     
260. SCHINDLER TH, Sadhu J
     Moving towards PET determined coronary flow capacity in outcome prediction after coronary revascularization?
     Int J Cardiol. 2024;405:131921.
     PubMed    
     
     
     
261. MUTLU D, Rempakos A, Alexandrou M, Al-Ogaili A, et al
     Emergency coronary artery bypass surgery after chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
     Int J Cardiol. 2024;405:131931.
     PubMed     Abstract available
     
     
     
262. TOFTHOLM MH, Hojstrup S, Talleruphuus U, Marner L, et al
     82-rubidium positron emission tomography determined myocardial flow reserve and outcomes following cardiac revascularisation - A multicentre registry study.
     Int J Cardiol. 2024;405:131865.
     PubMed     Abstract available
     
     
     
263. MATETIC A, Kyriacou T, Mamas MA
     Machine-learning clustering analysis identifies novel phenogroups in patients with ST-elevation acute myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132272. doi: 10.1016/j.ijcard.2024.132272.
     PubMed     Abstract available
     
     
     
264. ZHU Q, Cheang I, Guo Q, Lu X, et al
     Serum IGFBP5 as a predictor of major adverse cardiac events in patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132268. doi: 10.1016/j.ijcard.2024.132268.
     PubMed     Abstract available
     
     
     
265. CHEN Y, Zhang N, Gao Y, Zhou Z, et al
     A coronary CT angiography-derived myocardial radiomics model for predicting adverse outcomes in chronic myocardial infarction.
     Int J Cardiol. 2024 Jun 14:132265. doi: 10.1016/j.ijcard.2024.132265.
     PubMed     Abstract available
     
     
     
266. WANG L, Travieso A, van der Hoeven N, Lombardi M, et al
     Angiography-versus wire-based microvascular resistance index to detect coronary microvascular obstruction associated with ST-segment elevation myocardial infarction.
     Int J Cardiol. 2024 Jun 10:132256. doi: 10.1016/j.ijcard.2024.132256.
     PubMed     Abstract available
     
     
     
267. BANJAR S, Alharbi S, Omer I, Al Zaid N, et al
     Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis.
     Int J Cardiol. 2024;410:132239.
     PubMed     Abstract available
     
     
     
268. NISHIKAWA T, Kamada K, Morita H, Matsushita H, et al
     Automated control of Impella maintains optimal left ventricular unloading during periods of unstable hemodynamics and prevents myocardial damage in acute myocardial infarction.
     Int J Cardiol. 2024;410:132244.
     PubMed     Abstract available
     
     
     
269. MCCHORD J, Ong P
     Advancing precision medicine in INOCA research: The INOCA-IT registry.
     Int J Cardiol. 2024;404:131975.
     PubMed    
     
     
     
270. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
     Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
     Int J Cardiol. 2024;404:131972.
     PubMed     Abstract available
     
     
     
271. STERPETTI AV, Gabriele R, Di Marzo L
     Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
     Int J Cardiol. 2024;404:131937.
     PubMed    
     
     
     
272. BACIGALUPI E, Pelliccia F, Zimarino M
     Diabetes mellitus and in-stent restenosis: A direct link or something more?
     Int J Cardiol. 2024;404:131922.
     PubMed    
     
     
     
273. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
     Innate and adaptive immunity in acute myocarditis.
     Int J Cardiol. 2024;404:131901.
     PubMed     Abstract available
     
     
     May 2024
274. HONDA S, Lee S, Cho KH, Takegami M, et al
     Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction.
     Int J Cardiol. 2024 May 30:132197. doi: 10.1016/j.ijcard.2024.132197.
     PubMed     Abstract available
     
     
     
275. SUN L, Xu C, Zhang Z, Tang L, et al
     Physical activity lowers all-cause and cardio-cerebrovascular mortality in adults with coronary heart disease.
     Int J Cardiol. 2024;410:132225.
     PubMed     Abstract available
     
     
     
276. REA F
     Progress in cardiovascular mortality: Latest data on mortality from ischemic heart disease.
     Int J Cardiol. 2024;409:132192.
     PubMed    
     
     
     
277. CHEN G, Westra J, Yang X, Zhang Y, et al
     A simple Angio-based coronary flow assessment of culprit vessels in primary percutaneous coronary intervention is associated with long-term prognosis after ST-segment-elevation myocardial infarction.
     Int J Cardiol. 2024 May 21:132199. doi: 10.1016/j.ijcard.2024.132199.
     PubMed     Abstract available
     
     
     
278. WANG SR, Huang KC, Lin TT, Chuang SL, et al
     The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
     Int J Cardiol. 2024 May 21:132198. doi: 10.1016/j.ijcard.2024.132198.
     PubMed     Abstract available
     
     
     
279. UKITA K, Egami Y, Yano M, Nishino M, et al
     Reply to "Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?".
     Int J Cardiol. 2024;409:132187.
     PubMed    
     
     
     
280. YAO L, Hao K, Liu T, Jiang J, et al
     The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction.
     Int J Cardiol. 2024;409:132185.
     PubMed    
     
     
     
281. DIRJAYANTO VJ, Martin-Ruiz C, Pompei G, Rubino F, et al
     The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome.
     Int J Cardiol. 2024;409:132177.
     PubMed     Abstract available
     
     
     
282. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
     Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
     Int J Cardiol. 2024;403:131895.
     PubMed     Abstract available
     
     
     
283. XU P, Cao Y, Zhang S, Liu X, et al
     The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
     Int J Cardiol. 2024;403:131887.
     PubMed     Abstract available
     
     
     
284. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
     Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
     Int J Cardiol. 2024;403:131888.
     PubMed     Abstract available
     
     
     
285. SAARINEN SL, Borregaard B, Ekholm O, Christensen AV, et al
     Self-reported mental and physical health is associated with not returning to work in patients with ischemic heart disease.
     Int J Cardiol. 2024 May 15:132180. doi: 10.1016/j.ijcard.2024.132180.
     PubMed     Abstract available
     
     
     
286. LOPEZ-PALOP R, Carrillo P, Lozano I
     Transient new-onset atrial fibrillaation during acute coronary syndrome: Transient arrhythmia, transient risk?
     Int J Cardiol. 2024 May 14:132163. doi: 10.1016/j.ijcard.2024.132163.
     PubMed    
     
     
     
287. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
     Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
     Int J Cardiol. 2024;402:131889.
     PubMed     Abstract available
     
     
     
288. OLSEN FJ, Smiseth OA, Biering-Sorensen T
     Improving post-MI risk stratification with pressure-strain loops: Work in progress.
     Int J Cardiol. 2024;402:131866.
     PubMed    
     
     
     
289. DI VITO L, Di Giusto F, Grossi P
     Non-culprit plaque progression: What do we know?
     Int J Cardiol. 2024;402:131881.
     PubMed    
     
     
     
290. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
     "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
     Int J Cardiol. 2024;402:131859.
     PubMed     Abstract available
     
     
     
291. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
     Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
     Int J Cardiol. 2024;402:131819.
     PubMed     Abstract available
     
     
     April 2024
292. JHAND AS, Abusnina W, Tak HJ, Ahmed A, et al
     Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.
     Int J Cardiol. 2024 Apr 30:132111. doi: 10.1016/j.ijcard.2024.132111.
     PubMed     Abstract available
     
     
     
293. MIURA H, Koseki M, Ide S, Asaumi Y, et al
     Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction.
     Int J Cardiol. 2024 Apr 23:132099. doi: 10.1016/j.ijcard.2024.132099.
     PubMed     Abstract available
     
     
     
294. AL A, Babayigit E, Gorenek B
     Evaluation on mortality predictors after emergent percutaneous coronary intervention in acute myocardial infarction with ventricular arrhythmias: Details not to be ignored?
     Int J Cardiol. 2024;406:132079.
     PubMed    
     
     
     
295. GIRERD N
     The underappreciated value of resting heart rate in post-myocardial infarction follow-up.
     Int J Cardiol. 2024 Apr 19:132059. doi: 10.1016/j.ijcard.2024.132059.
     PubMed    
     
     
     
296. ANDO G, Lombardo L, Alagna G, Micari A, et al
     Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
     Int J Cardiol. 2024;401:131893.
     PubMed     Abstract available
     
     
     
297. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
     Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
     Int J Cardiol. 2024;401:131861.
     PubMed     Abstract available
     
     
     
298. HAN D, Hyun MC, Miller RJH, Gransar H, et al
     10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
     Int J Cardiol. 2024;401:131863.
     PubMed     Abstract available
     
     
     
299. TANNER R, Farhan S, Giustino G, Sartori S, et al
     Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
     Int J Cardiol. 2024;401:131856.
     PubMed     Abstract available
     
     
     
300. XIA B, Lu Y, Liang J, Li F, et al
     Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
     Int J Cardiol. 2024;401:131782.
     PubMed     Abstract available
     
     
     
301. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
     Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
     Int J Cardiol. 2024;401:131699.
     PubMed     Abstract available
     
     
     
302. WOLF S, Schievano E, Amidei CB, Kucher N, et al
     Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
     Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
     PubMed     Abstract available
     
     
     
303. YANG J, Zhao Y, Wang J, Ma L, et al
     Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
     Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
     PubMed     Abstract available
     
     
     
304. JONG CB, Lu TS, Chen JW
     Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
     PubMed    
     
     
     
305. UELAND T, Butt N, Lekva T, Orn S, et al
     High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
     Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
     PubMed     Abstract available
     
     
     
306. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
     Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
     Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
     PubMed    
     
     
     
307. PETERSEN JK, Butt JH, Yafasova A, Torp-Pedersen C, et al
     Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study.
     Int J Cardiol. 2024 Apr 6:132017. doi: 10.1016/j.ijcard.2024.132017.
     PubMed     Abstract available
     
     
     March 2024
308. CHENG Y, Zhang Q
     Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
     PubMed    
     
     
     
309. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
     Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
     Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
     PubMed     Abstract available
     
     
     
310. MCCORD J
     Identification and definition of type 2 myocardial infarction: Where do we go from here?
     Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
     PubMed    
     
     
     
311. VAN DEN BROEK WWA, Gimbel ME, Hermanides RS, Runnett C, et al
     The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.
     Int J Cardiol. 2024 Mar 7:131940. doi: 10.1016/j.ijcard.2024.131940.
     PubMed     Abstract available
     
     
     
312. GIACOBBE F, Giannino G, Annone U, Morena A, et al
     Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
     Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
     PubMed     Abstract available
     
     
     February 2024
313. POVLSEN AL, Helgestad OKL, Josiassen J, Christensen S, et al
     Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis.
     Int J Cardiol. 2024 Feb 27:131910. doi: 10.1016/j.ijcard.2024.131910.
     PubMed     Abstract available
     
     
     
314. BOURG C, Lee KC, Donal E
     Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
     Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
     PubMed    
     
     
     
315. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
     Impact of sex on the assessment of the microvascular resistance reserve.
     Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.